Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy

There is an association between nonalcoholic fatty liver disease (NAFLD) and the polycystic ovary syndrome (PCOS). Marine-derived omega-3 fatty acids have favorable effects on cardiovascular risk and could reduce liver fat in NAFLD. The primary aim of this study was to examine the effects of omega-3...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The journal of clinical endocrinology and metabolism Ročník 94; číslo 10; s. 3842
Hlavní autoři:	Cussons, Andrea J, Watts, Gerald F, Mori, Trevor A, Stuckey, Bronwyn G A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.10.2009
Témata:	Administration, Oral Adult Cross-Over Studies Dietary Supplements Drug Administration Schedule Fatty Acids, Omega-3 - administration & dosage Fatty Acids, Omega-3 - therapeutic use Fatty Liver - drug therapy Fatty Liver - etiology Female Humans Magnetic Resonance Spectroscopy - methods Middle Aged Obesity - complications Polycystic Ovary Syndrome - complications Protons
ISSN:	1945-7197, 1945-7197
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!